drug store, pharmacy, chain drug store, drugstore, community pharmacy, drug chain, retail pharmacy




























































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Week of   
























































































































































































































































Week of Mon, Feb 3rd, 2014

The Original Protein Shot grows distribution at CVS

Pro Balance Inc.'s The Original Protein Shot is getting an expanded presence at CVS/pharmacy.

Surescripts to showcase new health information solutions

Surescripts plans to demonstrate two new solutions, Record Locator & Exchange and CompletEPA, at this month's HIMSS14 Annual Conference & Exhibition in Orlando, Fla.

Valeant to acquire PreCision Dermatology

Valeant Pharmaceuticals International Inc. has entered an agreement to buy PreCision Dermatology Inc. for $475 million in cash

Chattem launches OTC Nasacort Allergy nasal spray

Chattem's Nasacort Allergy 24HR Nasal Spray has gone over the counter in the United States.

Pharma companies wrap up acquisitions

A trio of pharmaceutical companies — Endo Health Solutions, AstraZeneca and Forest Laboratories Inc. — closed key acquisition deals this week.

Crest introduces 3D White Brilliance Collection

Crest has added a pair of advanced products in its 3D White line with the launch of the Crest 3D White Brilliance Collection.

Gillette names soccer star Messi as ambassador

Gillette has signed professional soccer star Lionel Messi as a new global ambassador.

Altria to buy e-cigarette maker Green Smoke

Altria Group Inc. plans to acquire the electronic cigarette business of Green Smoke Inc. in a $110 million cash deal.

Actavis revamps global business organization

Actavis plc has realigned its global strategic business structure to reflect its stronger position in the specialty pharmaceutical space.

Advertisement